BIO CEO & Investor Conference

Feb 10-11, 2020・New York, New York

Partnering Investors

Below is a representative list of participating investors for the 2020 CEO & Investor Conference:

3E Bioventures
Acuitas Capital
Aditum Bio
Adjuvant Capital
AIG
Aisling Capital LLC
AJU IB INVESTMENT
Aleph Capital 
Alliance for Aging Research
Alliance for Cancer Gene Therapy
Alnitak capital
Andreessen Horowitz
Anson Funds
Aracle Capital LLC
ARCH Venture Partners
Arix Bioscience
Armistice Capital
Ascendiant Capital Markets
Ashford Capital Management
Aspire Capital
Astellas Pharma US
Astellas Venture Management
Astute Capital
ATEM Capital
Atheneos Ventures
AUGC
Ayrton Capital
Baidu
Baird
Bank of America Merrill Lynch
Berenberg Capital Markets
Bigger Capital Fund
Biocoast Capital
BioIdeations
BioInnovation Capital
Biondo Investment Advisors
Bios Partners
BioSense Global
Biotech Alliances International
Biotech Investment Group
Black Diamond Advisors
Bohe Angel Fund
Bojian Capital
Brace Pharma Capital
BTIG
Canaccord Genuity
Capital Family Office
Chaperone Investment
Chardan Capital Markets
Charlestown Capital
Chartwell
Church Pension Fund
CJ Seligman & Co.
Cowin Venture
Crosswave Management
CRV
CSC Leasing
CTI Capital Gestion Inc.
Dabar Investment Associates
DB Capital
Delaware Innovation Space
Deltec Bank
DHVC
District 2 Capital
Dynamk Capital
E Squared Asset Management
E Squared Capital
Easton Capital
Edgewood Management
EG Capital Advisors
Ensconce Capital
Esousa Holdings
ETP Global Fund
EVOLUTION Life Science Partners
Executive Forum Angels
Exome Asset Management
Fannin Innovation Studio
FC Capital
First Island Capital
First Seafront Fund Management
FMG Ventures
Fortress Biotech
Fountain Healthcare Partners
Frigate Capital Management
Global Neurohealth Ventures
Golden Eagle Capital Advisors
Good Health Capital
Grey Sky Venture Partners
H.C. Wainwright & Co.
H.I.G. BioHealth Partners/span>
H.I.G. Capital Management
Hannol Ventures
Harbin Pharmaceutical Group
Harvard Investors Group
Health Innovative Technology Corporation
HealthCare Royalty Partners
HEDA Ventures
Hercules Capital
HighCape Capital
Highland Capital Management
Hudson East Capital
Hyperplane VC
Ingenio Therapeutics / Mayewell Capital
Integrium
Intuitive
ISAR Capital Management
JH Darbie & Co.
J.W. Childs Associates
Jina Ventures
Johnston Associates
J.P. Morgan

K2 HealthVentures
Kalka Fund
Krensavage Asset Management
Ladenburg Thalman
Laidlaw Venture Partners
LifeNet Health
LifeScience EquityPartners
LifeTech Capital
Livingston
Lyfe Capital
Madryn Asset Management
Maxim Group
MedPro Investors
Merlin Nexus
Mid Atlantic Bio Angels
MIT Alumni Angels of Northern California
Mitsui & Co. Global Investment
Mizuho Corporate Bank
Mizuho Securities
MV Corp Services
MVP Capital Partners
NauVista Capital Management
NCL Technology Ventures
Network 1 Financial Securities
Neurotrope, Inc.
Newburgh Bay Capital
NGN Capital
Noble Equity Fund
Novatio Ventures
NSIP
NYC Medtech/Perselson
Oasis Capital
Oberland Capital
Oppenheimer & Co.
Opto Capital Group
Oracle Partners
OrbiMed Advisors
Orchard View Capital Advisors
Otsuka Pharmaceutical Co.
Pappas Capital
Park Ave. Capital Management International
Peak One Investments
Perseverance Capital Advisors
Piper Sandler
Premier Partners
Prevail Partners
Princeton Biopharma
Prism Biomedical Research
Promethean Capital Group
Quan Capital
Raymond James
Remsen Investors
RHK Capital
Rolin
Rosetta Capital
RW Baird
Sagard Holdings
Salubris Pharma
Sandhill Angels
Santen Pharmaceutical Co.
Satter Medical Technology Partnership
SDIC Fund Management
Sector Asset Management
Serrado Capital
Shanghai Henlius Biotech
Shaw Strategic Capital
Shenzhen Salubris Pharmaceuticals
Signature Bank
Sio Capital Management
SmithOnStocks
Sofinnova Ventures
SPRIM Ventures
SR One
Stonehenge Capital
Strathspey Crown
Sun Pharmaceuticals
Surveyor Capital
Tang Capital Management
The Anson Group
The Astrologers Fund
The Benchmark Company
The Center for Performance Investing
The Engine
The Leukemia & Lymphoma  Society
The Lind Partners
Tokyo Stock Exchange
Tosoh USA
University of Notre Dame
Upstream Partners
V2m Life Sciences Fund
Vector Resource Funds
Vista Capital Advisors
W Global Capital Limited
Western International
Westlake Ventures
Wexford Capital
Wolpert Associates
Xeraya Capital Life Venture
Yale University, Office of Cooperative Research
Young America Capital
Zacks Small Cap Research
ZJ Future 

 

*As of 1/15/2020